헬스케어 임상시험수탁기관 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 서비스별, 치료영역별, 분자별, 지역별, 부문 예측(2025-2030년)

Healthcare Contract Research Organization Market Growth & Trends:

The global healthcare contract research organization market size is estimated to reach USD 80.61 billion by 2030, registering to grow at a CAGR of 7.0% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites. However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market.

Over the past 5 years, the number of mergers and acquisitions significantly increased. Several large mergers have been witnessed since 2016 till 2023. Moreover, the trend of large transactions seems to be picking up since 2021, as in March 2022, M&B Sciences Inc, acquired Clara Health, which expanded M&B Sciences' access to digital technology-based clinical trials. Moreover, in December 2021, Thermo Fisher announced the acquisition of pharmaceutical services giant PPD, and in February 2021, ICON plc announced the acquisition of PRA Health Sciences. An era of consolidation has been witnessed around analytical technologies and software solutions used in the biopharmaceutical and pharmaceutical companies' services space. Hence, the aforementioned factors supported the market's growth.

Healthcare Contract Research Organization Market Report Highlights:

• Based on type, the clinical segment has dominated the global healthcare CRO market in 2024, with the largest share of 76.2% owing to the fact that it comprises four elaborate phases, including human subjects. The significant demand for new treatments has further contributed to the growth of the segment.
• Among services, the clinical monitoring segment was the largest in terms of market share at 19.91% in 2024.
• North America held a significant market share of 45.50% in 2024 due to the presence of several global players who invest a major part of their revenue in research activities.
• The healthcare Contract Research Organizations market in Asia Pacific is expected to grow at the fastest CAGR over the forecast period.
• China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence. China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Validation
  • 1.5.1. Region Wise Market: Base Estimates
  • 1.5.2. Global Market: CAGR Calculation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis (Model 1)
  • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
  • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
  • 1.6.4. Bottom-Up Approach (Model 4)
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Healthcare Contract Research Organizations (CRO) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Rate of Clinical Research To Boost Demand For Outsourcing Services
    • 3.2.1.2. Increasing Adoption Of Advanced Technologies
    • 3.2.1.3. Increasing Mergers and Collaborations
    • 3.2.1.4. Increasing Demand For Outsourcing Services Across The Developing Economies
    • 3.2.1.5. Patent Cliff
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Quality issues of CRO services
    • 3.2.2.2. Intellectual property rights issues
• 3.3. Technological Advancements
  • 3.3.1. Integration of AI and digital technologies
• 3.4. R&D Investment Perspective, by Sponsors
• 3.5. Clinical Trials Volume Analysis, 2024
  • 3.5.1. Total Number of Clinical Trials, by Region (2024)
  • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
  • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
  • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Research Organizations (CRO) Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Healthcare Contract Research Organizations (CRO) Market Movement Analysis
• 4.3. Global Healthcare Contract Research Organizations (CRO) Market Size & Trend Analysis, by Type, 2018 - 2030 (USD Million)
• 4.4. Drug Discovery
  • 4.4.1. Drug Discovery Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.4.2. Target Validation
    • 4.4.2.1. Target Validation Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.4.3. Lead Identification
    • 4.4.3.1. Lead Identification Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.4.4. Lead Optimization
    • 4.4.4.1. Lead Optimization Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 4.5. Pre-clinical
  • 4.5.1. Pre-clinical Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 4.6. Clinical
  • 4.6.1. Clinical Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.6.2. Phase I Trial Services
    • 4.6.2.1. Phase I Trial Services Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.6.3. Phase II Trial Services
    • 4.6.3.1. Phase II Trial Services Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.6.4. Phase III Trial Services
    • 4.6.4.1. Phase III Trial Services Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 4.6.5. Phase IV Trial Services
    • 4.6.5.1. Phase IV Trial Services Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Contract Research Organizations (CRO) Market: Service Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Healthcare Contract Research Organizations (CRO) Market Movement Analysis
• 5.3. Global Healthcare Contract Research Organizations (CRO) Market Size & Trend Analysis, by Service, 2018 - 2030 (USD Million)
• 5.4. Project Management/Clinical Supply Management
  • 5.4.1. Project Management/Clinical Supply Management Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.5. Data Management
  • 5.5.1. Data Management Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.6. Regulatory/Medical Affairs
  • 5.6.1. Regulatory/Medical Affairs Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.7. Medical Writing
  • 5.7.1. Medical Writing Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.8. Clinical Monitoring
  • 5.8.1. Clinical Monitoring Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.9. Quality Management/Assurance
  • 5.9.1. Quality Management/Assurance Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.10. Bio-statistics
  • 5.10.1. Bio-statistics Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.11. Investigator Payments
  • 5.11.1. Investigator Payments Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.12. Laboratory
  • 5.12.1. Laboratory Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 5.12.2. Sterility Testing
    • 5.12.2.1. Sterility Testing Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 5.12.3. Container/Closure Testing
    • 5.12.3.1. Container/Closure Testing Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 5.12.4. Extractables and Leachable Testing
    • 5.12.4.1. Extractables and Leachable Testing Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 5.12.5. Environmental Monitoring
    • 5.12.5.1. Environmental Monitoring Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 5.12.6. Disinfectant Efficacy Studies
    • 5.12.6.1. Disinfectant Efficacy Studies Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 5.12.7. Others
    • 5.12.7.1. Others Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.13. Patient and Site Recruitment
  • 5.13.1. Patient and Site Recruitment Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.14. Technology
  • 5.14.1. Technology Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 5.15. Others
  • 5.15.1. Others Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Contract Research Organizations (CRO) Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Healthcare Contract Research Organizations (CRO) Market Movement Analysis
• 6.3. Global Healthcare Contract Research Organizations (CRO) Market Size & Trend Analysis, by Therapeutic Area, 2018 - 2030 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. CNS Disorders
  • 6.5.1. CNS Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Infectious Diseases
  • 6.6.1. Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Immunological Disorders
  • 6.7.1. Immunological Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Cardiovascular Diseases
  • 6.8.1. Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Respiratory Diseases
  • 6.9.1. Respiratory Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. Diabetes
  • 6.10.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.11. Ophthalmology
  • 6.11.1. Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.12. Pain Management
  • 6.12.1. Pain Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.13. Others
  • 6.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Healthcare Contract Research Organizations (CRO) Market: Molecule Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Healthcare Contract Research Organizations (CRO) Market Movement Analysis
• 7.3. Global Healthcare Contract Research Organizations (CRO) Market Size & Trend Analysis, by Molecule, 2018 - 2030 (USD Million)
• 7.4. Pharmaceuticals
  • 7.4.1. Pharmaceuticals Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 7.4.2. Small Molecules
    • 7.4.2.1. Small Molecules Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
  • 7.4.3. Biologics
    • 7.4.3.1. Biologics Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)
• 7.5. Medical Device
  • 7.5.1. Medical Device Healthcare Contract Research Organization Market, 2018 - 2030 (USD Million)

Chapter 8. Healthcare Contract Research Organizations (CRO) Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Global Regional Market Snapshot
• 8.3. Market Size & Forecasts Trend Analysis, 2018 - 2030:
• 8.4. North America
  • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Switzerland
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Belgium
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Belgium Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.12. Netherlands
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competitive Scenario
    • 8.5.12.3. Regulatory Framework
    • 8.5.12.4. Netherlands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.13. Austria
    • 8.5.13.1. Key Country Dynamics
    • 8.5.13.2. Competitive Scenario
    • 8.5.13.3. Regulatory Framework
    • 8.5.13.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Japan
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.8. Taiwan
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Competitive Scenario
    • 8.6.8.3. Regulatory Framework
    • 8.6.8.4. Taiwan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.9. Indonesia
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Competitive Scenario
    • 8.6.9.3. Regulatory Framework
    • 8.6.9.4. Indonesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.10. Malaysia
    • 8.6.10.1. Key Country Dynamics
    • 8.6.10.2. Competitive Scenario
    • 8.6.10.3. Regulatory Framework
    • 8.6.10.4. Malaysia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.11. Singapore
    • 8.6.11.1. Key Country Dynamics
    • 8.6.11.2. Competitive Scenario
    • 8.6.11.3. Regulatory Framework
    • 8.6.11.4. Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. Colombia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Chile
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.6. Egypt
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Competitive Scenario
    • 8.8.6.3. Regulatory Framework
    • 8.8.6.4. Egypt Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.7. Israel
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Competitive Scenario
    • 8.8.7.3. Regulatory Framework
    • 8.8.7.4. Israel Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Competitive Market Share/Assessment Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. ICON Plc
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Charles River Laboratories
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Syneos Health
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. IQVIA Inc.
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. GVK Biosciences Private Limited (Aragen)
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. LabCorp
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Parexel International Corporation
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. WuXi AppTec
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Thermo Fisher Scientific Inc.
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. CTI Clinical Trial & Consulting
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. PSI
    • 9.3.11.1. Company Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Service Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. Medpace
    • 9.3.12.1. Company Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Service Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. Ergomed
    • 9.3.13.1. Company Overview
    • 9.3.13.2. Financial Performance
    • 9.3.13.3. Service Benchmarking
    • 9.3.13.4. Strategic Initiatives
  • 9.3.14. Worldwide Clinical Trials
    • 9.3.14.1. Company Overview
    • 9.3.14.2. Financial Performance
    • 9.3.14.3. Service Benchmarking
    • 9.3.14.4. Strategic Initiatives
  • 9.3.15. Medidata Solutions, Inc.
    • 9.3.15.1. Company Overview
    • 9.3.15.2. Financial Performance
    • 9.3.15.3. Service Benchmarking
    • 9.3.15.4. Strategic Initiatives
  • 9.3.16. Pharmaron GMBH
    • 9.3.16.1. Company Overview
    • 9.3.16.2. Financial Performance
    • 9.3.16.3. Service Benchmarking
    • 9.3.16.4. Strategic Initiatives
  • 9.3.17. SGS SA
    • 9.3.17.1. Company Overview
    • 9.3.17.2. Financial Performance
    • 9.3.17.3. Service Benchmarking
    • 9.3.17.4. Strategic Initiatives
  • 9.3.18. KCR S.A.
    • 9.3.18.1. Company Overview
    • 9.3.18.2. Financial Performance
    • 9.3.18.3. Service Benchmarking
    • 9.3.18.4. Strategic Initiatives
  • 9.3.19. Advanced Clinical Research Services, LLC.
    • 9.3.19.1. Company Overview
    • 9.3.19.2. Financial Performance
    • 9.3.19.3. Service Benchmarking
    • 9.3.19.4. Strategic Initiatives
  • 9.3.20. Pharm-Olam, LLC (Allucent)
    • 9.3.20.1. Company Overview
    • 9.3.20.2. Financial Performance
    • 9.3.20.3. Service Benchmarking
    • 9.3.20.4. Strategic Initiatives